Natalie Welty

Pharmacological characterization of a novel centrally permeable <scp>P2X7</scp> receptor antagonist: <scp>JNJ</scp>‐47965567

Anindya Bhattacharya, Qi Wang, Hong Ao et al. · British Journal of Pharmacology · 2013 · 198 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Selective blockade of the orexin-2 receptor attenuates ethanol self-administration, place preference, and reinstatement

James R. Shoblock, Natalie Welty, Leah Aluisio et al. · Psychopharmacology · 2010 · 159 citations

Life Sciences, Neuroscience, Pharmacology +15

Characterization of JNJ-42847922, a Selective Orexin-2 Receptor Antagonist, as a Clinical Candidate for the Treatment of Insomnia

Pascal Bonaventure, Jonathan Shelton, Sujin Yun et al. · Journal of Pharmacology and Experimental Therapeutics · 2015 · 82 citations

Medicine, Neuroscience, Pharmacology +14

In vitro and in vivo characterization of JNJ-31020028 (N-(4-{4-[2-(diethylamino)-2-oxo-1-phenylethyl]piperazin-1-yl}-3-fluorophenyl)-2-pyridin-3-ylbenzamide), a selective brain penetrant small molecule antagonist of the neuropeptide Y Y2 receptor

James R. Shoblock, Natalie Welty, Diane Nepomuceno et al. · Psychopharmacology · 2009 · 52 citations

Life Sciences, Neuroscience, Pharmacology +14

JNJ-39220675, a novel selective histamine H3 receptor antagonist, reduces the abuse-related effects of alcohol in rats

Ruggero Galici, Amir H. Rezvani, Leah Aluisio et al. · Psychopharmacology · 2010 · 47 citations

Medicine, Pharmacology, Psychiatry +12